Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial
about
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial dataOutcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched studyMild hyperkalemia and outcomes in chronic heart failure: a propensity matched studyGender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in womenEffectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial.Low-Dose Digoxin and Reduction in Mortality and Morbidity in Heart FailureEffects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched studyUncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population studyDEFEAT - Heart Failure: a guide to management of geriatric heart failure by generalist physicians.Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data.Intermittent low-dose digoxin may be effective and safe in patients with chronic heart failure undergoing maintenance hemodialysis.Digoxin associates with mortality in ESRD.Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.Characterization of the mechanisms of the increase in PPARδ expression induced by digoxin in the heart using the H9c2 cell line.Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF studyDigoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injuryOuabain prevents pathological cardiac hypertrophy and heart failure through activation of phosphoinositide 3-kinase α in mouse.Chronic Heart Failure Clinical Practice Guidelines' Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.DEFEAT heart failure: assessment and management of heart failure in nursing homes made easy.Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.Chronic heart failure in older adultsA propensity-matched study of low serum potassium and mortality in older adults with chronic heart failurePrediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort studyCurrent treatment of heart failure in the USA.Influence of sex on treatment and outcome in chronic heart failure.Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties.Heart failure in very old adults.The combination of digoxin and GSK2606414 exerts synergistic anticancer activity against leukemia in vitro and in vivo.Heart Failure with Preserved Ejection Fraction in Older Adults.Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions.Protein Interaction and Na/K-ATPase-Mediated Signal Transduction.Comparison of Digitalis Sensitivities of Na+/K+-ATPases from Human and Pig Kidneys.Study of digoxin use in a public health unit.Digoxin serum levels in patients with Chagas' cardiomyopathy and heart failure.The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failure.On van Gogh and the foxglove plant.Exposure to sennoside-digoxin interaction and risk of digoxin toxicity: a population-based nested case-control study.The previous use of digoxin does not worsen early outcome of acute coronary syndromes: an analysis of the ARIAM Registry.Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study.
P2860
Q26796271-D8A8BEE8-629F-47A1-BADB-095A44ABCDF1Q33718876-6B446EE4-205A-4A50-9B4A-B15BB25546E9Q33925600-6EE33DA6-0901-4B65-93F6-8D9EAC51AD80Q33926447-495821ED-9C09-4897-BFEA-3E6B532C0B9CQ33978533-B3B038AF-D333-4144-9C76-F4AF9F871282Q33997493-71C1D341-84C7-4C00-8A8D-B4FEC2F9D7FEQ34019065-C3FBB2AB-296E-48C7-BB36-0B107CE2822CQ34038855-7E1E43CB-A51A-4AF4-83C8-6EADE138613EQ34038879-4DDA7A1A-CE3E-4ED9-A7C7-9FC703C0E759Q34084146-27083F03-9110-4335-BD3F-1553931854BBQ34445112-9F9C0E24-C57B-4E4B-A1B2-01C920D82022Q34455390-36EA947E-DA6D-41D2-BC23-F6CE1A0B5382Q34647669-53BA0F32-7B19-4FC5-A47F-1E4390C52910Q34919685-DD028F59-E2BA-4BD8-B4AE-595853DA485FQ35511302-F25704E6-D72A-47EB-A897-3656378C48FBQ36041722-B695823A-7292-4564-9B7C-611C2B83879AQ36298545-58A20D72-454E-4A0E-B3C8-5EFA4B452F6CQ36661094-D50A468F-26B8-4397-9808-7A41F3D91DD5Q36817975-4141F82C-AB2E-4507-BE7E-AD69BE8F7813Q36837740-FB01D756-3D2A-435B-B7F8-54A7F750E287Q36860117-F226D086-0FFC-46B4-9583-6142B4EF6F63Q37131540-CCD890CD-D9B8-4F25-B212-657A1AA10509Q37407347-AD6E0D30-B54F-4FC3-8CC2-A548BBD6A693Q37612472-48FFDDDC-A693-4A50-A079-EA621A5779C4Q37688179-6672CB70-873A-4F6E-95C0-1A587322AA0CQ37877792-7F4A17F1-607D-4A70-8E06-523B46C0B4AAQ38127568-35C698F8-BDEF-4A30-A9F5-84379DC72DAEQ38148978-76D77185-8D40-4970-AF33-68B538B4831DQ38620165-11F728DA-6F05-4AD6-8D2D-A81144CE9A30Q38672337-7BED6D05-1885-4FFF-8056-CAA82AD33FB7Q38743215-355ED127-2DFC-4DF0-B1C1-D8E5CE4AA990Q39371897-43D22141-92FE-4356-A8ED-EC69827CE4E8Q41194437-E87C8A75-6FC6-45AB-8FFC-F7869D953EBFQ41726747-1BAB7D4F-2F2E-458A-8438-C13D89E9D5EAQ42803405-E2D88298-ABF5-404A-94F9-4D61C1A20DEDQ43190668-98429E39-CCBF-4D96-B467-1180A13A39C0Q48101230-FE0EED3A-8D6B-4B6E-A800-9CFE8D1D8AC1Q53149031-22AD9639-16B3-4F2A-A673-60E5D1D0D4D9Q54419973-DAB749F0-396B-4C04-BD7A-0378A0B48B1EQ55280835-1E5CD540-1372-4FC6-89D5-9C8899F116F2
P2860
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Effects of digoxin at low seru ...... matched study of the DIG trial
@ast
Effects of digoxin at low seru ...... matched study of the DIG trial
@en
type
label
Effects of digoxin at low seru ...... matched study of the DIG trial
@ast
Effects of digoxin at low seru ...... matched study of the DIG trial
@en
prefLabel
Effects of digoxin at low seru ...... matched study of the DIG trial
@ast
Effects of digoxin at low seru ...... matched study of the DIG trial
@en
P2093
P2860
P50
P921
P1476
Effects of digoxin at low seru ...... matched study of the DIG trial
@en
P2093
Finn Waagstein
Michel White
Shahbudin H Rahimtoola
Thomas E Love
P2860
P304
P356
10.1016/J.IJCARD.2006.12.001
P577
2007-03-23T00:00:00Z